Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Ustekinumab

1

I.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

1
Last update : 01/10/2013
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Ustekinumab associated chronic eosinophilic pneumonia.
The Journal of asthma : official journal of the Association for the Care of Asthma 2021 12;58;1670-1674 2021 12
61-Year-Old Man With Shortness of Breath and Cough.
Mayo Clinic proceedings 2021 08;96;2243-2247 2021 08
Association of Noninfectious Pneumonia With Ustekinumab Use.
JAMA dermatology 2019 02 01;155;221-224 2019 02 01
[Ustekinumab-induced eosinophilic pneumonia during the course of ustekinumab therapy for plaque psoriasis].
Annales de dermatologie et de venereologie 2015 Mar;142;193-6 2015 Mar
Psoriasis vulgaris complicated by eosinophilic pneumonia during ustekinumab treatment.
European journal of dermatology : EJD 2013 May-Jun;23;396-7 2013 May-Jun

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies